Condition
Platelet Rich Plasma (PRP)
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07669285Not ApplicableNot Yet Recruiting
Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women
NCT07579858Phase 3Completed
PRP Improves Blastocyst Formation in ICSI Cycles
NCT07005661Phase 2Not Yet Recruiting
Use of PRP in Open Surgery for Type A Aortic Dissection
NCT05787769Not ApplicableUnknown
A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.
NCT04456907Not ApplicableCompletedPrimary
Systemic Effects After Local Injection of Platelet-rich Plasma
Showing all 5 trials